OpenVSafe by OpenVAERS
Search V-safe

MXB-28110-98495

2 vaccinations 1 coded response 2 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
117 / NY
Registered
2021-07-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
EU6-19106-51524 Child or adolescent in my care · Male · 2021-07-07

Timeline

  1. 2021-01-11
    Dose 1 — Moderna
  2. 2021-02-08
    Dose 2 — Moderna
  3. 2021-07-07
    Registered in v-safe
  4. 2021-08-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  5. 2022-02-08
    Survey response — 12 months, dose 2
    MedDRA: Chest discomfort, Raynaud's phenomenon, Tachycardia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Tachycardia, chest discomfort, Raynaud's phenomenon
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-02-08
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  7. 2022-02-11

Vaccinations

DoseDateManufacturerCo-administered
12021-01-11Moderna No
22021-02-08Moderna No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 11 — 12 months, dose 2

2022-02-08

Symptoms: Tachycardia, chest discomfort, Raynaud's phenomenon

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest discomfort · · ✓
SDRaynaud's phenomenon · · ✓
SDTachycardia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release